Intravenous administration of antithrombin III induces indefinite survival of fully allogeneic cardiac grafts
To access this article, please choose from the options below
PII: S0041-1345(02)02908-1
© 2002 Elsevier Science Inc. All rights reserved.
PII: S0041-1345(02)02908-1
© 2002 Elsevier Science Inc. All rights reserved.